Although a mean of only 13.9% of tumor cells were positive for CD138 across all entities, certain subgroups such as MuEp, high-/intermediate MuEp, and SaDu lymph node metastases showed a CD138 expression in 25.2%, 34.8%, and 31.2% of tumor cells. Here, SDC1 is linked to neoplasm.